Integrated Cannabis Company Inc(CRPGF)
USD --+0.00%
Reward57Moderate
Risk43Moderate
📊75%Data
Thin 1% profit margin · 3.7% dividend yield
CRPGF
+0.0 · +0.00%
USD · PINK
Integrated Cannabis Company Inc | Healthcare
Value Trap
Market Cap:3.52Bn
ℹ️
Reward Rating
57
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
43
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on CRPGF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Integrated Cannabis Company Inc?

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

CRPGF · Verdict

Solid reward · moderate risk

CRPGF stands out on volatility and valuation, but watch the profitability signal.

Based on 88% data coverage

CRPGF · Verdict

What’s working & what to watch

Strengths 3

  • Volatility75/100

    Above average

  • Valuation70/100

    Above average

  • Growth66/100

    Rev +10.0% CAGR · earnings +2.8%

Watchouts 2

  • Profitability36/100

    1% net margin · 8% ROE

  • Balance sheet41/100

    Current ratio 1.41

Model-based scoring. For information only — not financial advice.

What is Integrated Cannabis Company Inc?

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 3.52B, and a P/E ratio of 7.0x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (57)

The scoring profile indicates moderate reward potential, with valuation and growth as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap3.52B
P/E Ratio7
Dividend Yield3.66%
52 Week High0.56
52 Week Low0.5429
Last AnnualJuly
IPO DateN/A
IncorporatedUSA
Shares Outstanding6B
No. of Employees86,000
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta-0.058
CurrencyUSD · Reports in CNY